Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Is hepatitis C virus core antigen an adequate marker for community screening?

Kuo YH, Chang KC, Wang JH, Tsai PS, Hung SF, Hung CH, Chen CH, Lu SN.

J Clin Microbiol. 2012 Jun;50(6):1989-93. doi: 10.1128/JCM.05175-11. Epub 2012 Mar 29.

2.

Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.

Medici MC, Furlini G, Rodella A, Fuertes A, Monachetti A, Calderaro A, Galli S, Terlenghi L, Olivares M, Bagnarelli P, Costantini A, De Conto F, Sainz M, Galli C, Manca N, Landini MP, Dettori G, Chezzi C.

J Clin Virol. 2011 Aug;51(4):264-9. doi: 10.1016/j.jcv.2011.05.003. Epub 2011 May 28.

PMID:
21621454
4.

Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup.

Gaudy C, Thevenas C, Tichet J, Mariotte N, Goudeau A, Dubois F.

J Clin Microbiol. 2005 Apr;43(4):1722-6.

5.

Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.

Alzahrani AJ.

J Med Virol. 2008 Apr;80(4):603-6. doi: 10.1002/jmv.21075.

PMID:
18297713
6.

Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.

Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G.

J Med Virol. 2004 Jul;73(3):397-403.

PMID:
15170635
7.

Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.

Yang JF, Lin YY, Hsieh MH, Tsai CH, Liu SF, Yu ML, Dai CY, Huang JF, Lin WY, Lin ZY, Chen SC, Chuang WL.

Kaohsiung J Med Sci. 2011 Jul;27(7):258-63. doi: 10.1016/j.kjms.2010.11.007. Epub 2011 Apr 20.

8.

[Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase].

Hmaïed F, Ben Mamou M, Arrouji Z, Slim A, Ben Redjeb S.

Pathol Biol (Paris). 2007 Mar;55(2):121-6. Epub 2006 May 2. French.

PMID:
16631320
10.

Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.

Wu S, Liu Y, Cheng L, Yin B, Peng J, Sun Z.

J Med Virol. 2011 Nov;83(11):1930-7. doi: 10.1002/jmv.22168.

PMID:
21915868
11.

Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.

Huang WS, Lu SN, Wang JH, Lee CM, Tung HD, Chen TM, ChangChien CS.

Hepatogastroenterology. 2005 May-Jun;52(63):893-6.

PMID:
15966227
12.

Analytical performance characteristics and clinical utility of a novel assay for total hepatitis C virus core antigen quantification.

Ross RS, Viazov S, Salloum S, Hilgard P, Gerken G, Roggendorf M.

J Clin Microbiol. 2010 Apr;48(4):1161-8. doi: 10.1128/JCM.01640-09. Epub 2010 Jan 27.

13.

Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection.

Laperche S, Le Marrec N, Girault A, Bouchardeau F, Servant-Delmas A, Maniez-Montreuil M, Gallian P, Levayer T, Morel P, Simon N.

J Clin Microbiol. 2005 Aug;43(8):3877-83.

14.

Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients.

Miedouge M, Saune K, Kamar N, Rieu M, Rostaing L, Izopet J.

J Clin Virol. 2010 May;48(1):18-21. doi: 10.1016/j.jcv.2010.02.012. Epub 2010 Mar 15.

PMID:
20233674
15.

Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results.

Kesli R, Polat H, Terzi Y, Kurtoglu MG, Uyar Y.

J Clin Microbiol. 2011 Dec;49(12):4089-93. doi: 10.1128/JCM.05292-11. Epub 2011 Sep 21.

16.
17.

Evaluation of a hepatitis C virus (HCV) antigen assay for routine HCV screening among men who have sex with men infected with HIV.

Vanhommerig JW, van de Laar TJ, Koot M, van Rooijen MS, Schinkel J, Speksnijder AG, Prins M, de Vries HJ, Bruisten SM.

J Virol Methods. 2015 Mar;213:147-50. doi: 10.1016/j.jviromet.2014.11.026. Epub 2014 Dec 18.

PMID:
25528203
18.

Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy.

Maynard M, Pradat P, Berthillon P, Picchio G, Voirin N, Martinot M, Marcellin P, Trepo C.

J Viral Hepat. 2003 Jul;10(4):318-23.

PMID:
12823600
19.

Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan.

Agha S, Tanaka Y, Saudy N, Kurbanov F, Abo-Zeid M, El-Malky M, Khalaf M, Ohta N, Yoshizawa H, Mizokami M.

J Med Virol. 2004 Jun;73(2):216-22.

PMID:
15122795
20.

Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.

Bouzgarrou N, Fodha I, Othman SB, Achour A, Grattard F, Trabelsi A, Pozzetto B.

J Med Virol. 2005 Dec;77(4):502-8.

PMID:
16254976

Supplemental Content

Support Center